Senior Manager, Global Case Management, Global Patient Safety Operations
Revolution Medicines
Summary
Provides operational oversight of end-to-end ICSR case processing across the product development lifecycle, ensuring activities performed by RevMed personnel and embedded FSP resources are conducted in accordance with applicable global regulatory requirements, RevMed procedures, data standards, and established case-processing timelines.
Job description
The Opportunity
Provides operational oversight of end-to-end ICSR case processing across the product development lifecycle, ensuring activities performed by RevMed personnel and embedded FSP resources are conducted in accordance with applicable global regulatory requirements, RevMed procedures, data standards, and established case-processing timelines.
- Maintains sponsor oversight and accountability for outsourced or delegated activities, including monitoring quality, compliance, workflow performance, and adherence to established processes.
- Maintains operational visibility of the end-to-end ICSR workflow from receipt and intake through processing, quality control, medical review, submission, follow-up and closure, ensuring clear ownership and timely resolution of workflow exceptions.
- Monitors day-to-day case-processing workflow health, quality and compliance using operational metrics/dashboards, including case intake/triage, processing timeliness, workflow aging, quality outcomes, follow-up activities, and late or potentially late cases.
- Identifies trends and operational risks and drives timely escalation, investigation and corrective and preventive actions, as appropriate.
- Provides day-to-day operational direction and support to embedded FSP resources; resolves case-processing questions, workflow issues and exceptions; clarifies procedural expectations; and coordinates escalation to appropriate RevMed subject-matter experts when required.
- Monitors case inventory and workflow progression from intake through case completion and submission, identifying aging inventory, bottlenecks, quality issues, missed milestones and compliance risks and ensuring appropriate remediation.
- Identifies trends and recurring issues; partners with FSP leadership and RevMed stakeholders on corrective actions and continuous improvement.
- Drives process improvement initiatives across people, process and technology to improve quality, compliance, efficiency, scalability and clarity of ownership.
- Reviews and approves case-processing exceptions and controlled case-management activities, including case deletions, case corrections, late-case investigations and other defined operational exceptions.
- Oversees vendor case-processing quality control, including risk-based case sampling, review of quality findings and tracking of corrections to completion.
- Reviews vendor quality metrics and recurring errors, agrees on remediation and training needs with vendor leadership, and monitors the effectiveness of corrective actions.
- Oversees vendor literature surveillance activities, ensuring searches and screening are completed and documented at the required frequency and potential ICSRs are routed promptly for assessment and processing.
- Monitors literature surveillance compliance, investigates missed or delayed reviews and ensures search records, screening decisions and supporting articles are maintained in an inspection-ready state.
- Develops and maintains case-management procedures, work instructions and training materials; ensures FSP resources are appropriately trained, qualified and equipped to perform assigned activities.
- Partners closely with GPS Safety Systems & Analytics to translate case-processing business needs into system requirements, identify workflow or configuration issues affecting case operations, support testing of enhancements and ensure system functionality supports compliant and efficient case processing.
- Leads process improvement initiatives and provides coaching and development to assigned staff; may manage direct reports.
Required Skills, Experience and Education
- Bachelor's degree in life sciences, pharmacy, nursing, or related discipline.
- Minimum of 5 years of relevant experience in pharmacovigilance operational activities.
- Strong practical knowledge of global pharmacovigilance and ICSR requirements across clinical development and post-marketing settings.
- Demonstrated hands-on experience with end-to-end ICSR case management, including intake/triage, case processing, quality control, medical-review interfaces, follow-up, reconciliation, regulatory submission workflows and case closure.
- Experience working with or overseeing embedded FSP, CRO and/or outsourced pharmacovigilance delivery models.
- Strong operational knowledge of Oracle Argus Safety or a comparable global safety database.
- Strong problem-solving skills and demonstrated ability to make sound operational decisions in time-sensitive situations.
- Ability to translate business and regulatory requirements into clear operational processes and to partner effectively with Safety Systems/IT teams.
- Excellent written and verbal communication skills.
- Ability to operate effectively in a fast-paced, cross-functional environment and manage multiple competing priorities.
- Demonstrated ability to influence and provide operational direction across matrixed teams without relying solely on direct reporting authority.
Preferred Skills
- Master's degree or higher in life sciences, pharmacy, nursing, medicine, public health, or a related healthcare/scientific discipline.
- 8+ years of progressive experience in pharmacovigilance/drug safety operations, with substantial experience in ICSR case management across both clinical development and post-marketing/marketed product environments.
- Demonstrated experience establishing, scaling, or transforming a pharmacovigilance operating model to support the transition of a clinical-stage biotechnology or pharmaceutical company to commercial-stage operations, including preparation for and/or execution of a first product launch.
Requirements
- Bachelor's degree in life sciences, pharmacy, nursing, or related discipline
- Minimum of 5 years of relevant experience in pharmacovigilance operational activities
- Strong practical knowledge of global pharmacovigilance and ICSR requirements across clinical development and post-marketing settings
- Demonstrated hands-on experience with end-to-end ICSR case management, including intake/triage, case processing, quality control, medical-review interfaces, follow-up, reconciliation, regulatory submission workflows and case closure
- Experience working with or overseeing embedded FSP, CRO and/or outsourced pharmacovigilance delivery models
- Strong operational knowledge of Oracle Argus Safety or a comparable global safety database
- Strong problem-solving skills and ability to make sound operational decisions in time-sensitive situations
- Ability to translate business and regulatory requirements into clear operational processes and partner with Safety Systems/IT teams
- Excellent written and verbal communication skills
- Ability to operate effectively in a fast-paced, cross-functional environment and manage multiple competing priorities
- Demonstrated ability to influence and provide operational direction across matrixed teams without relying solely on direct reporting authority
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.